Because the Department of Transportation (DOT) must follow the scientific guidelines of the HHS for DOT-regulated drug testing laboratory procedures, participants in the DOT transportation industry drug testing program should be aware of the important issues that HHS is considering. Any final rule issued by the HHS regarding these proposals will be taken into consideration and may affect the DOT testing program under 49 CFR Part 40, but only after the DOT conducts its own rulemaking.
Beginning November 18th 2024 FMCSA Clearinghouse Changes
Beginning November 18, 2024, State Drivers License Agencies (SDLAs) across the nation will be required to remove the commercial driving privileges of drivers in a
